Shimazaki T, Ishimaru S, Kawaguchi S, Koizumi N, Yokoi Y, Obitsu Y
Department of Surgery II, Tokyo Medical College, Japan.
Jpn J Thorac Cardiovasc Surg. 1998 Sep;46(9):868-72. doi: 10.1007/BF03217835.
We studied changes in blood coagulation and fibrinolytic system in 18 cases of thoracic aortic aneurysm and 5 cases of aortic dissection treated with stent grafts. The mean operation time was 259 +/- 67 minutes and the amount of blood loss during operation was 472 +/- 456 ml. Although blood transfusion of 220 +/- 360 ml was performed in 7 cases, 16 of 23 cases (70%) received no homologous blood transfusion. Consequently, the endoluminal stent graft treatment was minimally invasive compared with the conventional surgical procedure. On the 1st postoperative day, platelet counts and AT-III decreased and TAT increased. The promotion of blood coagulability was found in these patients on the 1st day after the operation. Changes in the fibrinolytic system were less marked than that in coagulation. These results suggest that the thrombosed aneurysm was excluded from systemic blood flow by the stent graft. There was no consumption coagulopathy in any case with aneurysm excluded by stent graft deployment. Stent-graft treatment for thoracic aortic aneurysm can be successfully performed without consumption coagulopathy when the aneurysm is completely excluded.
我们研究了18例胸主动脉瘤和5例接受支架植入治疗的主动脉夹层患者的凝血和纤溶系统变化。平均手术时间为259±67分钟,术中失血量为472±456毫升。虽然7例患者进行了220±360毫升的输血,但23例中有16例(70%)未接受同源输血。因此,与传统手术相比,腔内支架植入治疗的创伤最小。术后第1天,血小板计数和抗凝血酶III(AT-III)下降,凝血酶-抗凝血酶复合物(TAT)升高。术后第1天发现这些患者的血液凝固性增强。纤溶系统的变化不如凝血系统明显。这些结果表明,血栓形成的动脉瘤被支架植入物排除在体循环血流之外。在任何通过支架植入物排除动脉瘤的情况下,均未出现消耗性凝血病。当动脉瘤被完全排除时,胸主动脉瘤的支架植入治疗可以成功进行,而不会出现消耗性凝血病。